We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

98 hedge funds and large institutions have $10.3M invested in Vaxart in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,067% more call options, than puts

Call options by funds: $35K | Put options by funds: $3K

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

11% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 18

7% more funds holding

Funds holding: 92 → 98 (+6)

1.99% less ownership

Funds ownership: 11.98% → 9.99% (-2%)

7% less capital invested

Capital invested by funds: $11.1M → $10.3M (-$809K)

Holders
98
Holders Change
+6
Holders Change %
+6.52%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
20
Reduced
18
Closed
10
Calls
$35K
Puts
$3K
Net Calls
+$32K
Net Calls Change
+$27K

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$767K
2
Renaissance Technologies
Renaissance Technologies
New York
+$260K
3
UBS Group
UBS Group
Switzerland
+$116K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$97.1K
5
HF
HRT Financial
New York
+$77.8K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$2.27M
2
Millennium Management
Millennium Management
New York
-$411K
3
SCM
Silverarc Capital Management
Massachusetts
-$278K
4
Squarepoint
Squarepoint
New York
-$156K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$145K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
76
SBI Securities
Japan
$2.72K -$450 -1,035 -15%
Wells Fargo
77
Wells Fargo
California
$1.65K -$435 -1,000 -21%
PA
78
Parallel Advisors
California
$1.36K – – –
BNP Paribas Financial Markets
79
BNP Paribas Financial Markets
France
$1.15K +$29 +66 +3%
JP Morgan Chase
80
JP Morgan Chase
New York
$1K – – –
OP
81
ORG Partners
Indiana
$919 -$2.72K -6,250 -76%
CSC
82
Caldwell Sutter Capital
California
$904 – – –
MAFA
83
MJT & Associates Financial Advisory
Minnesota
$678 – – –
MCM
84
MAI Capital Management
Ohio
$452 – – –
Jones Financial Companies
85
Jones Financial Companies
Missouri
$134 +$43 +99 +57%
BCWM
86
Bartlett & Co Wealth Management
Ohio
$90 – – –
Fidelity Investments
87
Fidelity Investments
Massachusetts
$90 +$87 +200 New
GIA
88
GHP Investment Advisors
Colorado
$73 – – –
BTI
89
Blue Trust Inc
Georgia
$72 +$70 +160 New
LFG
90
Larson Financial Group
Missouri
$71 – – –
CTC
91
Central Trust Company
Missouri
$68 – – –
UB
92
UMB Bank
Missouri
$45 – – –
CWP
93
Concord Wealth Partners
Virginia
$34 – – –
TWC
94
TD Waterhouse Canada
Ontario, Canada
$16 – – –
BCM
95
Birch Capital Management
Texas
$10 – – –
AIC
96
Archer Investment Corporation
Indiana
$7 – – –
JFA
97
JNBA Financial Advisors
Minnesota
$3 +$2 +5 New
SIC
98
SJS Investment Consulting
Ohio
$2 – – –
SCM
99
Sio Capital Management
New York
– -$2.27M -5,583,448 Closed
SCM
100
Silverarc Capital Management
Massachusetts
– -$278K -683,825 Closed
1 2 3
4
5

VXRT Hedge Fund Activity: Q2 2025 in Review

98 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2025, worth a combined $10.3M — down 7.3% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new VXRT positions and 10 closed out — a net gain of 7 holders — while 20 added to existing stakes and 18 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $767K. The largest seller was Sio Capital Management, exiting entirely with an estimated $2.27M sold.

  • 98 institutional investors held Vaxart (VXRT) as of Q2 2025, up from 92 in Q1 2025.
  • Funds reported $10.3M of Vaxart stock for Q2 2025, down 7.3% quarter-over-quarter.
  • 17 funds opened new Vaxart positions in Q2 2025 and 10 closed out, a net change of +7 holders.
  • The largest Vaxart buyer in Q2 2025 was Marshall Wace, an estimated $767K added.
  • The largest Vaxart seller in Q2 2025 was Sio Capital Management, an estimated $2.27M sold.

Based on aggregated 13F filings for Q2 2025.